Ireland
--:--IST
Active, not recruiting Not applicable

Electric Stimulation Home Use(CGM MEPC_2401) for Improving Blood Circulation

NCT07446088 · tracked via the Priya Life Science South Korea tracker
Sponsor
Ceragem Clinical Inc
Phase
Not applicable
Started
2025-12-01
Last updated
2026-10-06

Condition(s) studied

Improving Blood CirculationBlood Circulation

Investigational drug(s) / intervention(s)

CERAGEM CELLTRON CIRCULATION CHAIR (CGM MEPC-2401)

CERAGEM CELLTRON CIRCULATION CHAIR (CGM MEPC-2401): Improving blood circulation device (Ceragem Celltron Circulation Chair)

Study summary

This study is a single-center, open-label, exploratory clinical trial to evaluate the safety and efficacy of a statics electricity generator for improving blood circulation.

Eligibility

Sex
ALL
Min age
19 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Adults aged between 19 and 65 years * Individuals with a BMI of 30.0 kg/m² or less * Individuals without abnormal findings on hematology tests (CBC) Exclusion Criteria: * Patients with uncontrolled hypertension despite medication (defined as systolic blood pressure ≥150 mmHg or diastolic blood pressure ≥100 mmHg measured at rest) * Patients with medical conditions requiring the use of assistive devices (e.g., pacemaker, artificial joint, stent, prosthesis, etc.) * Patients with seizure disorders or a history of loss of consciousness (e.g., epilepsy, acute febrile convulsions such as those associated with severe fever, etc.), or those at high risk of electric shock due to such conditions * Patients with ventricular arrhythmias (e.g., ventricular tachycardia, history of coronary artery bypass surgery, etc.) and patients with neurological disorders (e.g., diabetic neuropathy, etc.)

Primary outcome measure(s)

  • Change and percent change in blood flow of the dorsal metacarpal vein — from baseline to immediately after a 30-minute application of the investigational device
    Change and percent change in blood flow of the dorsal metacarpal vein from baseline to immediately after a 30-minute application of the investigational device

Trial sites (1)

FacilityCityRegionStatus
Wonju Severance Christian Hospital Wŏnju South Korea

More Ceragem Clinical Inc. trials in South Korea

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07446088 on ClinicalTrials.gov ↗ ← All trials in South Korea